Gender | Variable | No. 30/17 |
F/M | ||
JLS Subtype | No. (%) | |
Linear Scleroderma | 30 (63.8) | |
limbs/trunk | 11(23.4) | |
face | 19 (40.4) | |
PRS | 11(23.4) | |
ECDS | 8 (17) | |
Circumscribed Morphea | 7 (14.9) | |
Generalized Morphea | 4 (8.5) | |
Mixed | 6 (12.8) | |
Treatment | MTX | 21 (44.7) |
MTX, MMF | 3 (6.4) | |
PDN | 1 (2.1) | |
Age (yrs.) | mean ± S.D. | |
At onset | 7.34 ± 4.16 | |
At diagnosis | 8.57 ± 3.75 | |
At v1a | 13.40 ± 5.19 | |
Diagnostic Delay (yrs.) | 1.23 ± 1.46 | |
Disease Duration at v1a (yrs.) | 6.06 ± 4.46 |